What Happened
A 41-year-old licensed practical nurse pleaded guilty in federal court in Worcester on September 23, 2026, to tampering with a consumer product after diverting patients' oxycodone at a Fitchburg, Massachusetts healthcare facility and replacing it with lookalike pills.
According to the U.S. Attorney's Office for the District of Massachusetts, from about September 2024 through about February 2025 the LPN diverted oxycodone from patients in the facility's skilled nursing and dementia care units. The LPN began by taking oxycodone pills prescribed to be dispensed to certain patients "as needed" and consumed them rather than giving the doses to patients. The LPN took 5 mg oxycodone pills from various patients and replaced them with loratadine, an allergy medication whose appearance resembled the 5 mg tablets. In or around January 2025, the LPN also diverted 10 mg oxycodone pills from an elderly patient in the memory care unit and replaced them with levothyroxine, a thyroid medication.
The charge carries up to 10 years in prison, up to three years of supervised release and a fine of up to $250,000. Sentencing is scheduled for January 7, 2027; the LPN has not yet been sentenced.
What Went Wrong
- "As needed" doses were a single-person pathway. The diversion began with doses prescribed to be given as needed, and nothing confirmed that a removed dose actually reached the patient.
- Finished, patient-labelled oral product was diverted inside the unit. Because the pills were taken from patient supplies on the nursing unit, a substituted tablet looked like normal stock.
- Lookalike substitution defeated visual identification. Loratadine resembled the 5 mg oxycodone tablets, so a glance at the supply would not reveal the swap.
- Patients who could not report the problem were targeted. The diversion involved patients in skilled nursing, dementia and memory care units, including an elderly memory care patient, and patients receiving a substitute drug went without the prescribed medication.
How It Could Have Been Prevented
- Independent second check or direct observation of administration for high-risk controlled-substance doses, especially as-needed doses.
- Unit-dose packaging and reconciliation of patient-specific orders, comparing doses removed against doses documented as given and against patient response.
- Periodic inspection of patient medication supplies by someone other than the nurses with access, checking tablet identity (imprint, not just appearance) in cards and bottles.
- Pre-hire reference checks and licensure history review before granting access to controlled substances.
- An anonymous diversion reporting pathway so coworkers can raise concerns about unusual as-needed usage patterns.